# Safety and Preliminary Efficacy of Endoscopic Submucosal Injection of Hyaluronic Acid Into the Bladder Wall in Patients With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

> **NCT07658118** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Sverdlovsk Regional Clinical Hospital No.1** · enrollment: 15 (estimated)

## Conditions studied

- Cystitis, Interstitial
- Chronic Pain

## Interventions

- **DRUG:** Hyaluronic Acid (HA)

## Key facts

- **NCT ID:** NCT07658118
- **Lead sponsor:** Sverdlovsk Regional Clinical Hospital No.1
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2026-12
- **Final completion:** 2027-01
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07658118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07658118, "Safety and Preliminary Efficacy of Endoscopic Submucosal Injection of Hyaluronic Acid Into the Bladder Wall in Patients With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07658118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*